The vaccine trials of Coaxin for children have been approved in India. On May 12, the country's Drug Controller General of India (DCGI) has accepted the recommendation of the Subject Expert Committee and has allowed the second and third clinical trials of the India Biotech's Coronavirus Vaccine. This clinical trial will be done in the age group of 2 to 18 years.
- Category
- Asia
- Tags
- Bharat Biotech, Covaxin, Covid third wave
Sign in or sign up to post comments.
Be the first to comment